{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:10:11Z","timestamp":1758982211010,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.molimm.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T23:25:52Z","timestamp":1592695552000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Polyglutamine protein in tumor cells sensitizes tumor cells to natural killer cell cytolysis"],"prefix":"10.1016","volume":"124","author":[{"given":"Zhen","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2020.06.008_bib0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fimmu.2019.01999","article-title":"NK cell dysfunction and checkpoint immunotherapy","volume":"10","author":"Bi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrd.2018.133","article-title":"Therapeutic approaches to Huntington disease: from the bench to the clinic. Nature reviews","volume":"17","author":"Caron","year":"2018","journal-title":"Drug discovery"},{"key":"10.1016\/j.molimm.2020.06.008_bib0015","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.celrep.2017.03.010","article-title":"Enhanced degradation of misfolded proteins promotes tumorigenesis","volume":"18","author":"Chen","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molimm.2020.06.008_bib0020","article-title":"Augmented capacity to clear misfolded proteins: An intrinsic characteristic of tumor cells?","volume":"4","author":"Chen","year":"2017","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0025","first-page":"671","article-title":"Natural killer cells and other innate lymphoid cells in cancer. Nature reviews","volume":"18","author":"Chiossone","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2020.06.008_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2014.04.030","article-title":"A cellular system that degrades misfolded proteins and protects against neurodegeneration","volume":"55","author":"Guo","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molimm.2020.06.008_bib0035","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1172\/JCI129338","article-title":"Killers 2.0: NK cell therapies at the forefront of cancer control","volume":"129","author":"Hodgins","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.06.008_bib0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(12)70132-8","article-title":"Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden","volume":"13","author":"Ji","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.molimm.2020.06.008_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/icb.2013.96","article-title":"Cell biological steps and checkpoints in accessing NK cell cytotoxicity","volume":"92","author":"Mace","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: emergence of unifying mechanisms for huntington\u2019s disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.molimm.2020.06.008_bib0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-2006-954591","article-title":"Apoptosis of CD4+ T and natural killer cells in Alzheimer\u2019s disease","volume":"39","author":"Schindowski","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.molimm.2020.06.008_bib0065","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.0.CO;2-3","article-title":"Significantly lower incidence of cancer among patients with Huntington disease_ an apoptotic effect of an expanded polyglutamine tract","volume":"86","author":"Sorensen","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.molimm.2020.06.008_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri3044","article-title":"NK cell development, homeostasis and function: parallels with CD8+ T cells","volume":"11","author":"Sun","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2020.06.008_bib0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2020.06.008_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2020.06.008_bib0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.molimm.2018.08.015","article-title":"Impaired cytolytic activity of asthma-associated natural killer cells is linked to dysregulated transcriptional program in energy metabolism","volume":"101","author":"Wu","year":"2018","journal-title":"Mol. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020303862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020303862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:36:31Z","timestamp":1758980191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589020303862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"alternative-id":["S0161589020303862"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.06.008","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyglutamine protein in tumor cells sensitizes tumor cells to natural killer cell cytolysis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}